Saving cone cells in hereditary rod diseases: a possible role for rod-derived cone viability factor (RdCVF) therapy.
Sahel
José-Alain
JA
INSERM unit 592, France's Institute of Vision, The French National Center for Ophthalmology at the Quinze-Vingts Hospital in Paris, the Rothschild Foundation, and the University Paris VI.
D000818:Animals; D002470:Cell Survival / Q000502:physiology; D015785:Eye Diseases, Hereditary / Q000628:therapy*; D006801:Humans; D017949:Retinal Cone Photoreceptor Cells / Q000502:physiology*; D012162:Retinal Degeneration / Q000628:therapy*; D017948:Retinal Rod Photoreceptor Cells / Q000473:pathology*; D013879:Thioredoxins / Q000627:therapeutic use*
C488098:NXNL1 protein, human; D013879:Thioredoxins